β-secretase inhibitor drug
Evidence from:
primary |
all sources
Related entities (4)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| β-secretase inhibitor | targets | APP | — | 1 |
| β-secretase inhibitor | protective_against | Aβ accumulation | — | 1 |
| β-secretase inhibitor | interacts_with | neuronal cultures | — | 1 |
| β-secretase inhibitor | targets | β-secretase | — | 1 |
Mentioned in (2)
Papers in which this entity is mentioned.
- Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector. (2018)
- Self-Organizing 3D Human Neural Tissue Derived from Induced Pluripotent Stem Cells Recapitulate Alzheimer's Disease Phenotypes. (2016)
Merged raw entities (3)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| β-secretase inhibitor | drug | 2 | 3 |
| beta-secretase inhibitor | drug | 1 | 1 |
| om99-2 | drug | 1 | 1 |